Pivotal Phase 3 LUCIDITY trial of avexitide, a potential first-in-class GLP-1 receptor antagonist with FDA breakthrough therapy designation, underway in post-bariatric hypoglycemia (PBH); completion ...

Q1 2025 Earnings Call Transcript May 12, 2025 UroGen Pharma Ltd. misses on earnings expectations. Reported EPS is $-0.92 EPS, ...

Atea defines working capital as current assets less current liabilities. See the Company's condensed consolidated financial ...

Phase 1 clinical data of INB-100 continues to demonstrate long-term durable remissions, with 100% of treated Acute Myeloid ...

FDA PDUFA goal date of August 15, 2025, for TNX-102 SL for the management of fibromyalgia; if approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years Annou ...

Protalix BioTherapeutics, Inc. (AMEX: PLX) Q1 2025 Earnings Call Transcript May 9, 2025 Protalix BioTherapeutics, Inc. misses ...

In recognition of Construction Safety Week, leaders from Granite, Fluor, DPR and other firms talk about protecting workers on ...

Executives from companies such as Jacobs, Clayco and Shawmut detail overlooked areas for improving jobsite safety.

Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for ...

The Imperial Irrigation Board of Directors has unanimously declared May as Water Safety Month. This initiative aims to ...

Europe District construction personnel at construction field offices across the continent took a moment to discuss the importance of safety when working at heights and preventing falls in ...

The main goal of Helmet for Heroes, share the importance of safety. “Encourage them to be safe, to wear their helmet, and you know, on top of that, they can tell their friends, and then we get ...